PGA-SF core-shell scaffold capable of releasing IL-4 and TCP in dual mode, and preparation method and application of PGA-SF core-shell scaffold

CN118924950APending Publication Date: 2024-11-12HOSPITAL OF STOMATOLOGY SUN YAT SEN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410983314.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing PGA-SF core-shell stents have limited effects in promoting bone regeneration and mineralization, especially in the anti-inflammatory and promoting bone regeneration dynamics.

Method used

PGA-SF core-shell electrospinning scaffolds using dual-mode release IL-4 and TCP, and fiber scaffolds are constructed through electrospinning technology, using SF shell-carried interleukin 4 (IL-4) and PGA core-carried tricalcium phosphate (TCP) ), achieve the coordinated release of IL-4 and TCP to regulate inflammatory response and promote bone regeneration.

Benefits of technology

This scaffold can effectively limit early inflammation, promote macrophage polarization to M2 type, enhance osteogenic differentiation of BMSCs, significantly improve the bone regeneration effect in the body, and provide a microenvironment that is more suitable for bone healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924950A_ABST
    Figure CN118924950A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of bone defect repair, in particular to a PGA-SF core-shell stent capable of releasing IL-4 and TCP in a dual mode and a preparation method and application of the PGA-SF core-shell stent. The PGA-SF core-shell electrospinning stent capable of releasing the IL-4 and the TCP in the dual mode is formed by electrospinning prepared by adopting a coaxial electrospinning technology; the electrostatic spinning comprises a core made of a polyglycolic acid material and a shell made of a silk fibroin material; tricalcium phosphate is loaded in the core, and cytokine interleukin 4 is adsorbed on the shell. The cytokine interleukin 4 is continuously released in the early stage of material implantation so as to promote M2 type polarization of macrophages and limit excessive inflammatory response; the tricalcium phosphate is slowly released along with the degradation of the material, so that new bone regeneration and mineralization are realized. Under the synergistic effect of the two, the bone defect repairing requirement is better met, the technical problem that in the prior art, the anti-inflammatory effect and the bone regeneration and mineralization promoting effect of a bone defect repairing support are limited is solved, and the ideal application and popularization prospect is achieved.
Need to check novelty before this filing date? Find Prior Art